Purchases and Sales Made in Q3 2024 in Cue Biopharma, Inc. (CUE)
This table provides information about the institutional ownership of Cue Biopharma, Inc. (CUE) during Q3 2024. The information is specifically focused on institutions that hold shares of Cue Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Bleichroeder LP
New York, NY |
BUY
|
- |
2.14M+ 74.63% |
$961K - $2.31M
|
5M
$5.4M
|
|
|
Nov 01, 2024
Q3 2024
|
Sigma Planning Corp
Ann Arbor, MI |
BUY
|
- |
135K+ 50.86% |
$60.9K - $146K
|
401K
$433K
|
|
|
Oct 16, 2024
Q3 2024
|
Good Life Advisors, LLC
|
BUY
|
- |
75K+ 23.08% |
$33.8K - $81K
|
400K
$432K
|
|
|
Nov 14, 2024
Q3 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
27.7KNew |
$12.4K - $29.9K
|
27.7K
$29.9K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
16.4K+ 3.32% |
$7.37K - $17.7K
|
509K
$550K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
15.2K+ 25.69% |
$6.82K - $16.4K
|
74.2K
$80.1K
|
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
14.1K+ 5.08% |
$6.35K - $15.2K
|
292K
$315K
|
|
|
Nov 14, 2024
Q3 2024
|
Catalyst Funds Management Pty LTD
Sydney Nsw, C3 |
BUY
|
- |
9KNew |
$4.05K - $9.72K
|
9K
$9.72K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
BUY
|
- |
4.06KNew |
$1.83K - $4.38K
|
4.06K
$4.38K
|
|
|
Nov 12, 2024
Q3 2024
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
2K+ 400.0% |
$900 - $2.16K
|
2.5K
$2.7K
|
|
|
Nov 12, 2024
Q3 2024
|
Larson Financial Group LLC
|
BUY
|
- |
1.4KNew |
$630 - $1.51K
|
1.4K
$1.51K
|
|
|
Nov 14, 2024
Q3 2024
|
Stifel Financial Corp
St. Louis, MO |
BUY
|
- |
232+ 0.12% |
$104 - $251
|
194K
$210K
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-606- 2.93% |
$273 - $654
|
20.1K
$21.7K
|
|
|
Oct 28, 2024
Q3 2024
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-2.2K- 9.91% |
$990 - $2.38K
|
20K
$21.6K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-3.37K- 1.39% |
$1.51K - $3.64K
|
239K
$258K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.16K- 36.59% |
$1.87K - $4.5K
|
7.22K
$7.79K
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-5K- 99.15% |
$2.25K - $5.4K
|
43
$46.4
|
|
|
Nov 14, 2024
Q3 2024
|
Point72 (Difc) LTD
Dubai, C0 |
SELL
|
- |
-11.5K- 99.5% |
$5.16K - $12.4K
|
58
$62.6
|
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-12.3K- 67.05% |
$5.52K - $13.3K
|
6.03K
$6.51K
|
|
|
Nov 14, 2024
Q3 2024
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
SELL
|
- |
-28.9K- 54.56% |
$13K - $31.2K
|
24.1K
$26K
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-55.6K- 69.25% |
$25K - $60K
|
24.7K
$26.6K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-72.7K- 73.7% |
$32.7K - $78.5K
|
25.9K
$28K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-87.3K- 72.16% |
$39.3K - $94.3K
|
33.7K
$36.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-135K- 27.33% |
$60.8K - $146K
|
359K
$388K
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-200K- 93.19% |
$89.8K - $215K
|
14.6K
$15.7K
|
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-212K- 60.53% |
$95.4K - $229K
|
138K
$149K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-248K- 93.03% |
$112K - $268K
|
18.6K
$20K
|